1 – 20 of 317
- show: 20
- |
- sort: year (new to old)
- |
- Export
- 2024
- Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study (2024) CARDIOVASCULAR DRUGS AND THERAPY.
- Asthma exacerbations and eosinophilia in the UK Biobank : a genome-wide association study (2024) ERJ OPEN RESEARCH. 10(1).
- Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study (2024) EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 10(1). p.55-65
- The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (2024) THROMBOSIS AND HAEMOSTASIS. 124(2). p.135-148
- The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study (2024) RESPIRATORY RESEARCH. 25(1).
- Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF : a systematic review and meta-analysis (2024) DRUGS & AGING. 41. p.13-30
- 2023
- Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation : a qualitative approach (2023) THROMBOSIS RESEARCH. 229. p.164-169
- Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study (2023) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 89(4). p.1360-1373
- Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study (2023) EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 9(8). p.722-730
- Investigating levothyroxine use and its association with thyroid health in patients with hypothyroidism : a community pharmacy study (2023) THYROID. 33(8). p.918-926
- Drug-drug interactions with direct oral anticoagulants : development of a consensus list for ambulatory care (2023) INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 45(2). p.364-374
- The indispensable nasal decongestant : patients' views and perspectives on nasal decongestant overuse (2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 11(2). p.602-609.e1
- General health and working conditions of Flemish primary care professionals (2023) BMC PRIMARY CARE. 24(1).
- Methods to assess COPD medications adherence in healthcare databases : a systematic review (2023) EUROPEAN RESPIRATORY REVIEW. 32(169).
- The role of community pharmacists in primary and secondary prevention of skin cancer : an evaluation of a Flemish skin cancer prevention campaign (2023) BMC PUBLIC HEALTH. 23(1).
- Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study (2023) AGE AND AGEING. 52(3).
- Frailty transitions in older persons with lung function impairment : a population-based study (2023) JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 78(2). p.349-356
- Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis (2023) CARDIOVASCULAR DRUGS AND THERAPY. 37(4). p.781-791
- Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study (2023) IJC HEART & VASCULATURE. 47.
- Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study (2023) FRONTIERS IN PHARMACOLOGY. 14.